PNP
Purine nucleoside phosphorylase
Also known as: NP, PNPH_HUMAN, PUNP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P00491
- Gene
- PNP
- Ensembl
- ENSG00000198805
- Chromosome
- 14
- Canonical length
- 289 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
This gene encodes an enzyme which reversibly catalyzes the phosphorolysis of purine nucleosides. The enzyme is trimeric, containing three identical subunits. Mutations which result in nucleoside phosphorylase deficiency result in defective T-cell (cell-mediated) immunity but can also affect B-cell immunity and antibody responses. Neurologic disorders may also be apparent in patients with immune defects. A known polymorphism at aa position 51 that does not affect enzyme activity has been described. A pseudogene has been identified on chromosome 2. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
289 residues, UniProt reviewed canonical sequence.
>P00491|PNP
1 MENGYTYEDY KNTAEWLLSH TKHRPQVAII CGSGLGGLTD KLTQAQIFDY GEIPNFPRST
61 VPGHAGRLVF GFLNGRACVM MQGRFHMYEG YPLWKVTFPV RVFHLLGVDT LVVTNAAGGL
121 NPKFEVGDIM LIRDHINLPG FSGQNPLRGP NDERFGDRFP AMSDAYDRTM RQRALSTWKQ
181 MGEQRELQEG TYVMVAGPSF ETVAECRVLQ KLGADAVGMS TVPEVIVARH CGLRVFGFSL
241 ITNKVIMDYE SLEKANHEEV LAAGKQAAQK LEQFVSILMA SIPLPDKASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PNP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 551 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 551 nTPM
- bone marrow: 299 nTPM
- kidney: 192 nTPM
- placenta: 124 nTPM
- duodenum: 113 nTPM
- urinary bladder: 93 nTPM
Single-cell type
- syncytiotrophoblasts: 732 nCPM
- epididymal principal cells: 505 nCPM
- cytotrophoblasts: 472 nCPM
- breast lactating cells: 263 nCPM
- megakaryocytes: 210 nCPM
- platelets: 208 nCPM
Immune cell
- MAIT T-cell: 73 nTPM
- myeloid DC: 48 nTPM
- memory CD8 T-cell: 45 nTPM
- memory CD4 T-cell: 44 nTPM
- gdT-cell: 39 nTPM
- NK-cell: 38 nTPM
Brain region
- spinal cord: 25 nTPM
- cerebellum: 24 nTPM
- cerebral cortex: 24 nTPM
- thalamus: 21 nTPM
- medulla oblongata: 20 nTPM
- pons: 19 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PNP.
Disease | AllUniProt
Conditions PNP is implicated in, by any mechanism.
- Purine nucleoside phosphorylase deficiency (PNPD) MIM:613179
Disease | GeneticClinVar
38 pathogenic / likely-pathogenic of 310 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Purine-nucleoside phosphorylase deficiency
- Severe combined immunodeficiency disease
- Acute myeloid leukemia
Disease | ImmuneIEDB
Conditions an epitope on PNP was assayed in.
- Behcet's disease T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.15
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.44
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- allantoin metabolic process
- dAMP catabolic process
- deoxyadenosine catabolic process
- deoxyinosine catabolic process
- immune response
- IMP catabolic process
- inosine catabolic process
- nucleobase-containing compound metabolic process
- nucleotide biosynthetic process
- positive regulation of alpha-beta T cell differentiation
- positive regulation of interleukin-2 production
- positive regulation of T cell proliferation
- purine ribonucleoside salvage
- purine-containing compound salvage
- response to xenobiotic stimulus
- urate biosynthetic process
- nicotinamide riboside catabolic process
Molecular functions
- guanosine phosphorylase activity
- identical protein binding
- nucleoside binding
- phosphate ion binding
- purine nucleobase binding
- purine-nucleoside phosphorylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nucleoside phosphorylase domain
- Purine phosphorylase, family 2, conserved site
- Nucleoside phosphorylase superfamily
- Phosphorylase superfamily
- Purine nucleoside phosphorylase
- Purine nucleoside phosphorylase I, inosine/guanosine-specific
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PNP as an antibody target. Whether an autoantibody or antibody against PNP could matter depends on whether native PNP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PNP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- Mutations which result in nucleoside phosphorylase deficiency result in defective T-cell (cell-mediated) immunity but can also affect B-cell immunity and antibody responses.
Loading the interactive Seroatlas protein explorer...